Does ALPROSTADIL ALFADEX Cause Systemic scleroderma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Systemic scleroderma have been filed in association with ALPROSTADIL ALFADEX. This represents 11.1% of all adverse event reports for ALPROSTADIL ALFADEX.
5
Reports of Systemic scleroderma with ALPROSTADIL ALFADEX
11.1%
of all ALPROSTADIL ALFADEX reports
5
Deaths
5
Hospitalizations
How Dangerous Is Systemic scleroderma From ALPROSTADIL ALFADEX?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization.
Is Systemic scleroderma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPROSTADIL ALFADEX. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ALPROSTADIL ALFADEX Cause?
Stevens-johnson syndrome (9)
Sepsis (7)
Toxic epidermal necrolysis (7)
Peripheral arterial occlusive disease (6)
Right ventricular failure (6)
Anal polyp (5)
Blood pressure abnormal (5)
Cardiac dysfunction (5)
Dermatitis allergic (5)
Disease progression (5)
What Other Drugs Cause Systemic scleroderma?
RITUXIMAB (54)
CYCLOPHOSPHAMIDE (53)
MACITENTAN (52)
DOCETAXEL (49)
METHOTREXATE (45)
MYCOPHENOLATE MOFETIL (44)
FLUOROURACIL (34)
SELEXIPAG (34)
TREPROSTINIL (34)
BOSENTAN (30)